Which antiseptic wins? new trial tests C-Section infection prevention
NCT ID NCT05920122
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two different skin cleansers used before cesarean sections to see which one better prevents wound infections. About 1,400 women having C-sections at one hospital were randomly assigned to get either a plain chlorhexidine solution or one mixed with alcohol. Researchers tracked infections within 30 days after surgery, along with other complications like endometritis and hospital readmissions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Chlorhexidine gluconate with isopropyl alcohol
What this could lead to
If one cleanser works better, hospitals may adopt it to reduce infections after C-sections, making surgery safer for mothers.
What could go wrong
This is a single-center study, so results may not apply everywhere. Both cleansers are already in use, so no major breakthrough is expected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURGICAL SITE INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15260, United States